wize pharma, inc. is a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, including des. wize has in-licensed certain rights to purchase, market, sell and distribute a formula known as lo2a, a drug developed for the treatment of des, and other ophthalmological illnesses, including cch and sjögren's syndrome (sjögren's). lo2a is currently registered and marketed by its inventor in germany and switzerland for the treatment of des, in hungary for the treatment of des, cch and sjögren's and in the netherlands for the treatment of des and sjögren's. wize's strategy involves engaging local or multinational distributors to handle the distribution of lo2a. wize has finished a phase ii trial of lo2a for patients with cch and is currently conducting a phase iv study for lo2a for des in patients with sjögren's.
Company profile
Ticker
MIGI
Exchange
Website
CEO
Noam Danenberg
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
DENALI CONCRETE MANAGEMENT INC, OphthaliX, Inc., Wize Pharma, Inc.
SEC CIK
Corporate docs
Subsidiaries
Mawson Infrastructure Group Pty Ltd • Mawson AU Ltd • MIG No. 1 Pty Ltd • Mawson Services Pty Ltd • Cosmos Trading Pty Ltd • Cosmos Manager LLC • Cosmos Infrastructure LLC • Luna Squares Repairs LLC • Luna Squares LLC • Luna Squares Property LLC ...
IRS number
880445169
MIGI stock data
Latest filings (excl ownership)
8-K
Mawson Infrastructure Group Inc. Announces Monthly Operational Update for March 2024
18 Apr 24
8-K
Mawson Infrastructure Group Inc. Announces New Board Chair
15 Apr 24
8-K
Mawson Infrastructure Group Inc. Reports Q4 and Fiscal Year 2023 Financial Results
1 Apr 24
10-K
2023 FY
Annual report
29 Mar 24
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
29 Mar 24
8-K
Entry into a Material Definitive Agreement
27 Mar 24
8-K
Mawson Infrastructure Group Inc. Announces Monthly Operational Update for February 2024
19 Mar 24
8-K
Unregistered Sales of Equity Securities
8 Mar 24
S-8
Registration of securities for employees
6 Mar 24
8-K
Departure of Directors or Certain Officers
23 Feb 24
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.50 mm | 1.50 mm | 1.50 mm | 1.50 mm | 1.50 mm | 1.50 mm |
Cash burn (monthly) | 1.37 mm | (no burn) | 6.44 mm | 5.97 mm | 208.53 k | 1.31 mm |
Cash used (since last report) | 9.33 mm | n/a | 43.88 mm | 40.67 mm | 1.42 mm | 8.91 mm |
Cash remaining | -7.83 mm | n/a | -42.38 mm | -39.18 mm | 76.82 k | -7.41 mm |
Runway (months of cash) | -5.7 | n/a | -6.6 | -6.6 | 0.4 | -5.7 |
Institutional ownership, Q2 2023
40.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 13 |
Opened positions | 4 |
Closed positions | 3 |
Increased positions | 3 |
Reduced positions | 3 |
13F shares | Current |
---|---|
Total value | 3.43 bn |
Total shares | 6.74 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Inbocalupo PTY | 4.89 mm | $4.13 mm |
Armistice Capital | 1.38 mm | $2.61 bn |
Segantii Capital Management | 198.67 k | $375.48 mm |
Monograph Wealth Advisors | 86.65 k | $163.77 mm |
Vident Investment Advisory | 64.34 k | $121.61 mm |
BLK Blackrock | 30.40 k | $57.45 mm |
Toroso Investments | 22.17 k | $42.00 k |
Jane Street | 13.29 k | $25.12 mm |
CIBC Asset Management | 12.43 k | $23.49 mm |
Harvest Portfolios | 12.02 k | $22.71 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Mar 24 | Ryan Costello | RSU Common Stock | Grant | Acquire A | No | No | 0 | 118,395 | 0.00 | 118,395 |
4 Mar 24 | Rahul Mewawalla | RSU Common Stock | Grant | Acquire A | No | No | 0 | 1,482,226 | 0.00 | 1,482,226 |
4 Mar 24 | Rahul Mewawalla | RSU Common Stock | Grant | Acquire A | No | No | 0 | 1,587,302 | 0.00 | 1,587,302 |
22 Nov 23 | Rahul Mewawalla | RSU Common Stock | Other | Dispose J | No | No | 0 | - | NaN | 0 |
21 Nov 23 | Ryan Costello | RSU Common Stock | Other | Dispose J | No | No | 0 | - | NaN | 0 |
21 Nov 23 | Rahul Mewawalla | RSU Common Stock | Other | Dispose J | No | No | 0 | - | NaN | 0 |
21 Nov 23 | Ryan Costello | RSU Common Stock | Grant | Acquire A | No | No | 0 | 118,395 | 0.00 | 118,395 |
29 Jun 23 | Rahul Mewawalla | Stock Option Common Stock | Other | Dispose J | No | No | 0 | - | NaN | 0 |
News
12 Information Technology Stocks Moving In Thursday's Intraday Session
18 Apr 24
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
10 Apr 24
HC Wainwright & Co. Reiterates Buy on Mawson Infra Gr, Maintains $3 Price Target
4 Apr 24
Mawson Infra Gr Q4 EPS $(0.76) Misses $(0.73) Estimate, Sales $14.02M Beat $9.75M Estimate
1 Apr 24
Cantor Fitzgerald Reiterates Neutral on Mawson Infra Gr, Maintains $1 Price Target
1 Apr 24
Press releases
Mawson Infrastructure Group Inc. Announces Monthly Operational Update for March 2024
18 Apr 24
Mawson Infrastructure Group Inc. Announces New Board Chair
15 Apr 24
Mawson Infrastructure Group Expands Co-Location Business
27 Mar 24
Mawson Infrastructure Group Inc. Announces Monthly Operational Update for February 2024
19 Mar 24
Mawson Infrastructure Group Inc. Announces Monthly Operational Update for January 2024
16 Feb 24